Guideline for stress ulcer prophylaxis in the intensive care unit
- PMID: 24814922
Guideline for stress ulcer prophylaxis in the intensive care unit
Abstract
Stress ulcer prophylaxis (SUP) is commonly used in the intensive care unit (ICU), and is recommended in the Surviving Sepsis Campaign guidelines 2012. The present guideline from the Danish Society of Intensive Care Medicine and the Danish Society of Anesthesiology and Intensive Care Medicine sums up current evidence and gives clinical recommendations for SUP in the ICU. The GRADE approach was used for grading the evidence (www.gradeworkinggroup.org). In conclusion, existing meta-analyses have been underpowered to reach firm conclusions. We recommend not using SUP routinely for adult critically ill patients in the ICU outside the context of randomized controlled trials (GRADE 1C). No robust evidence supports recommendations for subpopulations in the ICU such as septic, burn, trauma, cardiothoracic or enterally fed patients. However, if SUP is considered clinically indicated in individual patients, we suggest using proton pump inhibitors over histamine-2-receptor antagonists (GRADE 2C).
Similar articles
-
Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.Pharmacotherapy. 2019 Mar;39(3):408-420. doi: 10.1002/phar.2172. Epub 2018 Sep 6. Pharmacotherapy. 2019. PMID: 30101529
-
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.Trials. 2016 Apr 19;17(1):205. doi: 10.1186/s13063-016-1331-3. Trials. 2016. PMID: 27093939 Free PMC article. Clinical Trial.
-
Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study.Intern Med J. 2023 Mar;53(3):389-396. doi: 10.1111/imj.15598. Epub 2022 Aug 13. Intern Med J. 2023. PMID: 34697866
-
Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.Crit Care Med. 2014 Apr;42(4):809-15. doi: 10.1097/CCM.0000000000000032. Crit Care Med. 2014. PMID: 24365863
-
When should stress ulcer prophylaxis be used in the ICU?Curr Opin Crit Care. 2009 Apr;15(2):139-43. doi: 10.1097/MCC.0b013e32832978e0. Curr Opin Crit Care. 2009. PMID: 19578324 Review.
Cited by
-
Pharmacist-Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review.Front Pharmacol. 2021 Oct 25;12:741724. doi: 10.3389/fphar.2021.741724. eCollection 2021. Front Pharmacol. 2021. PMID: 34759821 Free PMC article. Review.
-
The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.J Gastroenterol Hepatol. 2021 Aug;36(8):2131-2140. doi: 10.1111/jgh.15432. Epub 2021 Feb 15. J Gastroenterol Hepatol. 2021. PMID: 33586808 Free PMC article.
-
Stress ulcer prophylaxis use in critical care units at public hospitals in Johannesburg, South Africa.South Afr J Crit Care. 2021 Mar 17;37(1):10.7196/SAJCC.2021.v37i1.439. doi: 10.7196/SAJCC.2021.v37i1.439. eCollection 2021. South Afr J Crit Care. 2021. PMID: 35498762 Free PMC article.
-
The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.Int J Clin Pharm. 2015 Dec;37(6):1152-61. doi: 10.1007/s11096-015-0178-0. Epub 2015 Aug 30. Int J Clin Pharm. 2015. PMID: 26319396
-
Stress-related mucosal disease in the critically ill patient.Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):98-107. doi: 10.1038/nrgastro.2014.235. Epub 2015 Jan 6. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25560847 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical